High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes

被引:60
|
作者
Tahhan, Ayman Samman [1 ]
Sandesara, Pratik [1 ]
Hayek, Salim S. [1 ]
Hammadah, Muhammad [1 ]
Alkhoder, Ayman [1 ]
Kelli, Heval M. [1 ]
Topel, Matthew [1 ]
O'Neal, Wesley T. [1 ]
Ghasemzadeh, Nima [1 ]
Ko, Yi-An [2 ,3 ]
Gafeer, Mohamad Mazen [1 ]
Abdelhadi, Naser [1 ]
Choudhary, Fahad [1 ]
Patel, Keyur [1 ]
Beshiri, Agim [6 ]
Murtagh, Gillian [6 ]
Kim, Jonathan [1 ]
Wilson, Peter [1 ]
Shaw, Leslee [1 ]
Vaccarino, Viola [1 ,4 ,5 ]
Epstein, Stephen E. [7 ]
Sperling, Laurence [1 ]
Quyyumi, Arshed A. [1 ]
机构
[1] Emory Univ, Sch Med, Div Cardiol, Emory Clin Cardiovasc Res Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Biostat, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Bioinformat, Atlanta, GA 30322 USA
[4] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA
[5] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[6] Abbott Labs, Div Diagnost, N Chicago, IL 60064 USA
[7] MedStar Washington Hosp Ctr, MedStar Heart & Vasc Inst, Washington, DC USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2018年 / 7卷 / 05期
基金
美国国家卫生研究院;
关键词
atherosclerosis; coronary angiography; coronary artery disease; troponin; C-REACTIVE-PROTEIN; CARDIAC TROPONIN; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEART-DISEASE; ASSAY; RISK; POPULATION; ISCHEMIA; PLAQUE;
D O I
10.1161/JAHA.117.007914
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The associations between high-sensitivity troponin I (hsTnI) levels and coronary artery disease (CAD) severity and progression remain unclear. We investigated whether there is an association between hsTnI and angiographic severity and progression of CAD and whether the predictive value of hsTnI level for incident cardiovascular outcomes is independent of CAD severity. Methods and Results-In 3087 patients (aged 63 +/- 12years, 64% men) undergoing cardiac catheterization without evidence of acute myocardial infarction, the severity of CAD was calculated by the number of major coronary arteries with >= 50% stenosis and the Gensini score. CAD progression was assessed in a subset of 717 patients who had undergone >= 2 coronary angiograms >3months before enrollment. Patients were followed up for incident all-cause mortality and incident cardiovascular events. Of the total population, 11% had normal angiograms, 23% had nonobstructive CAD, 20% had 1-vessel CAD, 20% had 2-vessel CAD, and 26% had 3-vessel CAD. After adjusting for age, sex, race, body mass index, smoking, hypertension, diabetes mellitus history, and renal function, hsTnI levels were independently associated with the severity of CAD measured by the Gensini score (log 2 beta=0.31; 95% confidence interval, 0.18-0.44; P<0.001) and with CAD progression (log 2 beta=0.36; 95% confidence interval, 0.14-0.58; P=0.001). hsTnI level was also a significant predictor of incident death, cardiovascular death, myocardial infarction, revascularization, and cardiac hospitalizations, independent of the aforementioned covariates and CAD severity. Conclusions-Higher hsTnI levels are associated with the underlying burden of coronary atherosclerosis, more rapid progression of CAD, and higher risk of all-cause mortality and incident cardiovascular events. Whether more aggressive treatment aimed at reducing hsTnI levels can modulate disease progression requires further investigation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] High-Sensitivity Troponin T Level and Angiographic Severity of Coronary Artery Disease
    Ndrepepa, Gjin
    Braun, Siegmund
    Schulz, Stefanie
    Mehilli, Julinda
    Schoemig, Albert
    Kastrati, Adnan
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (05) : 639 - 643
  • [2] High-sensitivity cardiac troponin T is associated with coronary artery calcification
    Kitagawa, Noriyuki
    Okada, Hiroshi
    Tanaka, Muhei
    Hashimoto, Yoshitaka
    Kimura, Toshihiro
    Tomiyasu, Kiichiro
    Nakano, Koji
    Hasegawa, Goji
    Nakamura, Naoto
    Fukui, Michiaki
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2015, 9 (03) : 209 - 214
  • [3] Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease
    Al-Badri, Ahmed
    Tahhan, Ayman Samman
    Sabbak, Nabil
    Alkhoder, Ayman
    Liu, Chang
    Ko, Yi-An
    Vaccarino, Viola
    Martini, Mohamed Afif
    Sidoti, Arianna
    Goodwin, Cydney
    Ghazzal, Bahjat
    Beshiri, Agim
    Murtagh, Gillian
    Mehta, Puja K.
    Quyyumi, Arshed
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (08):
  • [4] High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis
    Kvisvik, Brede
    Morkrid, Lars
    Rosjo, Helge
    Cvancarova, Milada
    Rowe, Alexander D.
    Eek, Christian
    Bendz, Bjorn
    Edvardsen, Thor
    Gravning, Jorgen
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2017, 51 (03): : 395 - 407
  • [5] High-Sensitivity Troponin and Coronary Artery Disease Severity A Bridge Too Far?
    Quyyumi, Arshed A.
    Tahhan, Ayman Samman
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (06) : 1056 - 1057
  • [6] High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease
    Ford, Ian
    Shah, Anoop S. V.
    Zhang, Ruiqi
    McAllister, David A.
    Strachan, Fiona E.
    Caslake, Muriel
    Newby, David E.
    Packard, Chris J.
    Mills, Nicholas L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (25) : 2719 - 2728
  • [7] Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease
    Brunner, Fabian J.
    Kroeger, Friederike
    Blaum, Christopher
    Gossling, Alina
    Lorenz, Thiess
    van Erckelens, Elisabeth
    Braetz, Julian
    Westermann, Dirk
    Blankenberg, Stefan
    Zeller, Tanja
    Waldeyer, Christoph
    Seiffert, Moritz
    ATHEROSCLEROSIS, 2020, 313 : 81 - 87
  • [8] High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis
    Kvisvik, Brede
    Morkrid, Lars
    Rosjo, Helge
    Cvancarova, Milada
    Rowe, Alexander D.
    Eek, Christian
    Bendz, Bjorn
    Edvardsen, Thor
    Gravning, Jorgen
    CLINICAL CHEMISTRY, 2017, 63 (02) : 552 - 562
  • [9] High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease
    Wereski, Ryan
    Adamson, Philip
    Daud, Nur Shazlin Shek
    McDermott, Michael
    Taggart, Caelan
    Bularga, Anda
    Kimenai, Dorien M.
    Lowry, Mathew T. H.
    Tuck, Chris
    Anand, Atul
    Lowe, David J.
    Chapman, Andrew R.
    Mills, Nicholas L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (06) : 473 - 485
  • [10] Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial
    Kaldal, Anete
    Tonstad, Serena
    Jortveit, Jarle
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)